West Pharmaceutical Services | WST - Debt


West Pharmaceutical Services reported $202.8M in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
Align Technology USD 121.27M 1.75M Sep/2025
Avanos Medical USD 133.7M 3.6M Sep/2025
Baxter International USD 9.71B 13M Sep/2025
Becton, Dickinson and Co. USD 19.54B 358M Dec/2025
Cerus USD 84.16M 791K Dec/2024
Charles River Laboratories USD 2.63B 157.4M Sep/2025
Cooper Companies USD 2.48B 285.1M Jun/2025
Dentsply International USD 2.49B 159M Jun/2025
Haemonetics USD 1.22B 54K Sep/2025
ICU Medical USD 1.28B 79.88M Dec/2025
Insulet USD 1.01B 384.9M Sep/2025
Integra LifeSciences USD 2.01B 170.48M Jun/2025
IQVIA Holdings USD 15.72B 767M Dec/2025
J&J USD 45.8B 4.97B Sep/2025
Medtronic USD 29.1B 491M Sep/2025
Merit Medical Systems USD 821.15M 599K Sep/2025
Neogen USD 792.53M 101.58M Jun/2025
OraSure Technologies USD 782K 465K Jun/2024
Quidel USD 2.84B 51.1M Sep/2025
Repligen USD 542.21M 146.65M Dec/2025
Solventum Corp USD 7.91B 97M Mar/2025
STAAR Surgical USD 40.52M 40.14M Jun/2025
Terumo JPY 159.87B 14.97B Sep/2025
Utah Medical Products USD 0 0 Mar/2022
West Pharmaceutical Services USD 202.8M 100K Dec/2025